Articles with public access mandates - Claudio ArraLearn more
Not available anywhere: 3
Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferation
A Dicitore, M Caraglia, G Gaudenzi, G Manfredi, B Amato, D Mari, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 42-52, 2014
Mandates: Government of Italy
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer
G Palma, C Conte, A Barbieri, S Bimonte, A Luciano, D Rea, F Ungaro, ...
International journal of pharmaceutics 473 (1-2), 55-63, 2014
Mandates: Government of Italy
Phosphonium salt displays cytotoxic effects against human cancer cell lines
D Dhanya, P Giuseppe, CA Rita, M Annaluisa, SM Stefania, G Francesca, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017
Mandates: Government of Italy
Available somewhere: 47
Microbiota effects on cancer: from risks to therapies
D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ...
Oncotarget 9 (25), 17915, 2018
Mandates: Government of Italy
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
L Mele, F Paino, F Papaccio, T Regad, D Boocock, P Stiuso, A Lombardi, ...
Cell death & disease 9 (5), 572, 2018
Mandates: Government of Italy
Ranolazine protects from doxorubicin‐induced oxidative stress and cardiac dysfunction
CG Tocchetti, A Carpi, C Coppola, C Quintavalle, D Rea, M Campesan, ...
European journal of heart failure 16 (4), 358-366, 2014
Mandates: Government of Italy
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases
L Portella, R Vitale, S De Luca, C D’Alterio, C Ierano, M Napolitano, ...
PloS one 8 (9), e74548, 2013
Mandates: Government of Italy
Management of QT prolongation induced by anti-cancer drugs: target therapy and old agents. Different algorithms for different drugs
C Coppola, A Rienzo, G Piscopo, A Barbieri, C Arra, N Maurea
Cancer treatment reviews 63, 135-143, 2018
Mandates: Government of Italy
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs
F Esposito, M De Martino, MG Petti, F Forzati, M Tornincasa, A Federico, ...
Oncotarget 5 (18), 8341, 2014
Mandates: Government of Italy
Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype
A Federico, F Forzati, F Esposito, C Arra, G Palma, A Barbieri, D Palmieri, ...
Biology open 3 (5), 372-378, 2014
Mandates: Government of Italy
Mouse models in prostate cancer translational research: from xenograft to PDX
D Rea, V Del Vecchio, G Palma, A Barbieri, M Falco, A Luciano, ...
BioMed research international 2016 (1), 9750795, 2016
Mandates: Government of Italy
Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
F Bruzzese, B Pucci, MR Milone, C Ciardiello, R Franco, MI Chianese, ...
Cell death & disease 4 (10), e878-e878, 2013
Mandates: Government of Italy
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration
G Chiappetta, T Valentino, M Vitiello, R Pasquinelli, M Monaco, G Palma, ...
Oncotarget 6 (7), 5310, 2015
Mandates: US National Institutes of Health
The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth
G Chiappetta, A Basile, A Barbieri, A Falco, A Rosati, M Festa, ...
Oncotarget 5 (16), 6846, 2014
Mandates: Government of Italy
Cancer-associated CD43 glycoforms as target of immunotherapy
FM Tuccillo, C Palmieri, G Fiume, A De Laurentiis, M Schiavone, ...
Molecular cancer therapeutics 13 (3), 752-762, 2014
Mandates: US National Institutes of Health, Government of Italy
Ranolazine attenuates trastuzumab-induced heart dysfunction by modulating ROS production
G Riccio, S Antonucci, C Coppola, C D'Avino, G Piscopo, D Fiore, ...
Frontiers in physiology 9, 38, 2018
Mandates: US National Institutes of Health, Government of Italy
Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model
M Tagliamonte, A Petrizzo, M Napolitano, A Luciano, C Arra, P Maiolino, ...
Cancer Immunology, Immunotherapy 64, 1305-1314, 2015
Mandates: Government of Italy
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice
G Fiume, A Scialdone, F Albano, A Rossi, F Maria Tuccillo, D Rea, ...
Scientific reports 5 (1), 13864, 2015
Mandates: Government of Italy
A Urokinase receptor–derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting
K Bifulco, I Longanesi-Cattani, E Liguori, C Arra, D Rea, MT Masucci, ...
Molecular cancer therapeutics 12 (10), 1981-1993, 2013
Mandates: Government of Italy
The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA. MB231 cells
S Bimonte, A Barbieri, M Cascella, D Rea, G Palma, V Del Vecchio, ...
OncoTargets and therapy, 185-191, 2018
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program